Fact check: Hydroxychloroquine does not work better

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
174
Fact check: Hydroxychloroquine does not work better abroad

Ella Lee

USA TODAY

https://www.usatoday.com/story/news/factcheck...311483001/

The claim: Hydroxychloroquine works in other countries, but not in the U.S.

As some global leaders tout the effectiveness of hydroxychloroquine against COVID-19, scientists from those countries caution that there’s not much evidence it works, putting the drug at the center of political debate.

A meme shared by The Rabbit Hole, a Facebook page that often reposts right-wing memes and often veers into QAnon territory, claims that while top U.S. medical professionals say the drug doesn’t work, it’s working just fine in other countries.

“Hydroxychloroquine works in Spain, Italy, Brazil. Mexico, France, Germany & elsewhere,” the Facebook post reads. “The only place hydroxychloroquine does not work is the USA, according to Dr. Fauci.”

The post has been shared over 2,300times, and comments criticize the renouncement of the drug by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

“The man has sold his soul, he now works for the Dems in big Pharma! Needs to be replaced” one commenter wrote.

Fact check:Hydroxychloroquine has not worked in treating COVID-19, studies show

Hydroxychloroquine is no more effective abroad than in the U.S.
Hydroxychloroquine is an immunosuppressive drug that was developed decades ago to prevent and treat malaria. It’s also used to treat autoimmune diseases like systemic lupus erythematous and rheumatoid arthritis.


The drug made its way into mainstream conversation after some global leaders, including President Donald Trump, claimed it could be a COVID-19 treatment.

But many scientists and studies have made it clear the drug has not worked in treating COVID-19 – and might even be dangerous.

Fact check:'Thousands' of doctors have not said hydroxychloroquine cures COVID-19


France, Italy and Belgium all moved to stop the use of hydroxychloroquine in May , shortly after the World Health Organization decided to pause a large trial of the drug due to safety concerns. WHO has now discontinued that trial. Germany paused its trial for the same reasons, but is now conducting one trial in patients with mild cases of COVID-19.

Brazil President Jair Bolsonaro, who contracted COVID-19 in early July, has pushed for Brazilians to use hydroxychloroquine, saying he used it for his own treatment.

“This was my experience,” he said. “Twelve hours after taking that first dose of hydroxychloroquine, I was 100% better. So, it worked for me. I’m the living proof.”

But scientists in Brazil say there’s no hard evidence hydroxychloroquine is working there. A clinical trial conducted at 55 hospitals across Brazil found the drug to be ineffective, according to a study published July 23 in the New England Journal of Medicine .

In May, Mexico received a donation of hydroxychloroquine that it used to treat 20,000 patients Forbes Mexico reported. Mexico also tops the list of most expensive purchases of hydroxychloroquine, Mexican newspaper La Jornada reported.

But in July, Gustavo Reyes Terán, head of the Coordinating Commission of the National Institutes of Health and High Specialty Hospitals in Mexico, said that there was no evidence the drug works against COVID-19, Milenio, a Spanish-language magazine, reported.


“Hydroxychloroquine is one of the drugs that does have an in-vitro effect in the test tube," he said. "Experimenting with cells reduces viral infection and also has an anti-inflammatory effect. In theory, it was one of the ideal drugs, but when it is carried in a clinical trial it is different, in the human body it is different. Hydroxychloroquine has not shown efficacy."

When most countries stopped testing hydroxychloroquine, Spaincontinued to use the drug against the coronavirus, according to El País, a Spanish-language daily newspaper in Spain. But after putting the drug through tests, top Spanish scientists found the drug failed as a method to prevent COVID-19.

The countries using or lauding hydroxychloroquine as a treatment — Mexico, Spain, Brazil and the U.S. — are not doing any better than other countries taking different approaches and are ranked as needing action, according to data from EndCoronavirus.org, an international coalition of several thousand volunteers, including scientists and community organizers.

Fauci says hydroxychloroquine does not work, studies back him up

Facebook page The Rabbit Hole pointed to a study put out by the Henry Ford Hospital System in southeast Michigan in response to USA TODAY’s request for comment. That study, released July 2, found that death rates were 50% lower among patients treated with hydroxychloroquine and that the drug posed no safety problems.

Fauci and others called the study flawed, pointing to a number of issues.


"The Henry Ford hospital study ... was confounded by a number of issues, including the fact that many of the people who are receiving hydroxychloroquine were also receiving corticosteroids, which we know from another study gives a clear benefit in reducing deaths with advanced disease," Fauci said during a congressional hearing July 31.

"So that study is a flawed study. ... When I do see a randomized placebo-controlled trial that looks at any aspect of hydroxychloroquine — either early study, middle study or late — if that randomized placebo-controlled trial shows efficacy, I would be the first one to admit it and to promote it."

The study was also criticized as an observational study, which is less rigorous than a randomized trial, USA TODAY reported.

In response to the criticism, the Henry Ford Health System released an open letter, citing its dismay that the current political climate has “made any objective discussion about this drug impossible.”

Multiple other studies have backed up Fauci’s statements, USA TODAY reported.

Our rating: False

We rate the claim that hydroxychloroquine works in other countries, but not in the U.S., as FALSE because it was not supported by our research. None of the countries listed have seen success greater than or equal to the U.S. in treating COVID-19 with the drug. Studies show the drug does not work, and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, backs up that fact.

Our fact-check sources:

Medline Plus, June 15, Hydroxychloroquine
President Donald Trump tweet, March 21
USA TODAY, July 21, Fact check: Hydroxychloroquine has not worked in treating COVID-19, studies show
Reuters, May 27, France, Italy, Belgium to stop use of hydroxychloroquine for coronavirus over safety fears
The Guardian, May 25, WHO halts hydroxychloroquine trial for coronavirus amid safety fears
World Health Organization, July 4, WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
Reuters, May 28, Germany pauses anti-malaria drug study for COVID-19: Spiegel
ClinicalTrials.gov, May 11, Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)
BBC News, July 8, Coronavirus: Brazil's President Bolsonaro tests positive
The World, July 22, Why is Brazil's Bolsonaro peddling hydroxychloroquine despite the science?
The New England Journal of Medicine, July 23, Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Mexico News Daily, May 23, Despite doubts, Mexico to administer hydroxychloroquine to 20,000
WION News, May 28, Spain will not stop use of HCQ to treat COVID-19 patients, unlike other European nations
Forbes Mexico, May 11, Novartis dona hidroxicloroquina en México para hacer pruebas en 20,000 pacientes con Covid-19
La Jornada, July 6, Los medicamentos se encarecen hasta 60%
Milenio, July 9, Estos son los fármacos que no han mostrado efectividad contra el covid-19
El Pais, May 27, España seguirá usando la hidroxicloroquina frente al coronavirus pese a la prohibición de Francia y las dudas de la OMS
El Pais, June 12, La hidroxicloroquina fracasa como método para prevenir la covid-19, según el ensayo de Oriol Mitjà
EndCoronavirus.org, accessed Aug. 18
Henry Ford Health System, July 2, Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows
PBS News Hour on YouTube, July 31, Widely cited hydroxychloroquine study is ‘flawed’, Fauci tells hearing
Henry Ford Health System, Aug. 3, Hydroxychloroquine: An Open Letter to Our Community and Beyond
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlocalMe Unveils Mobile Connectivity Innovations at IFA 2026

Updated Category News Views 0

Stepping into the Connectivity Future at IFA 2026 GlocalMe, a name synonymous with global mobile connections, made a splash at the IFA 2026 in Berlin. Equipped with a lineup built for the future, their presentation focused on lifestyle gadgets designed for constant online access. In a world where digital connection feels as vital as air, they've aligned perfectly with the...

Continue Reading
Cypress Wood's Resilience in Louisiana's Humidity

Updated Category News Views 1

Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
SimpliTrain's Momentum in LMS Market Heating Up

Updated Category News Views 0

SimpliTrain Finds its Groove in the LMS Arena Out here in Delray Beach, SimpliTrain's making waves in the Learning Management System (LMS) market, recently snagging the 'Pervasive Player' tag from MarketsandMarkets' 360Quadrants platform. This cloud-based learning powerhouse ain't just playing around; they're doubling down with expansion into AI and other fancy tech bits...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 0

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
LIV Golf's Big Play: Restructuring with Saudi PIF

Updated Category News Views 0

Trailblazing Change in the Golf World It's like watching a high-stakes game of chess where pieces are worth billions. White Knight Capital Corp. has thrown its hat into the ring with the Public Investment Fund of Saudi Arabia to overhaul LIV Golf Enterprises. This isn't your average Monday morning golf chat; it's full-on corporate drama with financial steroids. Debt Swap...

Continue Reading
HoneyNaps Unveils Wireless PSG: Sleep Testing Revolution

Updated Category News Views 2

Tearing Down the Wired Wall in Sleep Studies Well, here's a switch-up that's long overdue in the world of sleep disorders diagnostics. It looks like HoneyNaps has figured out how to ditch the tangled mess that is traditional polysomnography (PSG) with their new creation—a wireless PSG system, and I gotta say, I'm liking the sound of that. If you've ever been strapped to...

Continue Reading
Baidu Joins Shanghai-HK Connect, Expanding Reach

Updated Category News Views 0

Big News from Baidu: Connect Program Inclusion Bet you didn't see this one coming. Baidu, the titan of AI in China, just rolled out some significant buzz. Starting September 7th, their Class A ordinary shares will join the Shanghai-Hong Kong Stock Connect program, shaking things up on the Shanghai Stock Exchange. This move is set to give investors from the Chinese...

Continue Reading
NOVOSENSE's Bold Performance Amid Rapid IC Demand

Updated Category News Views 1

Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 4

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading

Top 5 Most Recently Viewed Articles

QuantumScape's Recent Performance and Market Outlook Explained

Updated Category News Views 177

QuantumScape's Stock Performance Overview QuantumScape Corp (NYSE: QS) is making headlines as its stock rises significantly in response to the latest quarterly results, showcasing a promising trajectory for the company. This boost follows an announcement regarding the successful shipment of B1 samples featuring the advanced QSE-5 cell technology, meeting key performance...

Continue Reading
Nokia Corporation: Recent Managers' Transactions Update

Updated Category News Views 48

Managers' Transactions at Nokia Corporation Nokia Corporation has recently notified about a critical transaction involving one of its managers, which falls under the Article 19 notification requirement of the EU Market Abuse Regulation. This is an essential aspect of corporate governance and transparency in the financial markets. Details of the Notification On a specified...

Continue Reading
Top Programmatic Ad Sellers in Brazil: Q3 Insights

Updated Category News Views 247

Understanding Brazil's Programmatic Ad Market Rankings for Q3 2024 In an evolving digital landscape, understanding the quality of programmatic ad sellers is crucial for marketers and advertisers. With Q3 2024 drawing insights from the renowned Pixalate, the Brazil programmatic ad seller quality rankings have emerged, shedding light on the premier players in both web and...

Continue Reading
Chicago Atlantic REIT Announces Special Dividend for Investors

Updated Category News Views 122

Chicago Atlantic Real Estate Finance Declares Dividends Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a prominent commercial mortgage real estate investment trust (REIT), has recently made a significant announcement for its investors. The board of directors has declared a regular quarterly cash dividend of $0.47 for the fourth quarter. This regular dividend...

Continue Reading
Cibus Inc. Updates on Underwriters' Option and Recent Developments

Updated Category News Views 69

Cibus Inc. Announces Partial Exercise of Underwriters' Option Cibus Inc., a key player in the agricultural chemicals industry, has generated buzz with the announcement that it has partially exercised its option with its underwriters in connection with its recent public offering. This action follows the decision by representatives from Roth Capital Partners and...

Continue Reading